Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Somo-InSIGHT Study, Breast Cancer Screening Study Beginning Early 2009 Enrolling Over 20,000 Women
http://www.medicalnewstoday.com/articles/130760.php
U-Systems, the innovative leader in dedicated breast ultrasound systems, today announced its plans to conduct a multi-center breast cancer screening study named <i>somo•InSIGHT</i>, with more than 20,000 women, using its proprietary Automated Breast Ultrasound System (ABUS).
Breakthrough Breast Cancer Comment Re Research Suggesting Breast Screening May Detect Cancers That Would Have Otherwise Regressed
http://www.medicalnewstoday.com/articles/130669.php
Dr Alexis Willett from Breakthrough Breast Cancer says: "This research puts forward an interesting theory about breast cancer development. However, it is not currently possible to predict whether early changes picked up by breast screening will progress so treatment is usually offered to prevent breast cancer developing.
Mammograms May Identify Cancers That Would Otherwise Just Regress
http://www.medicalnewstoday.com/articles/130644.php
Researchers in Norway found there was a 22 per cent higher rate of detected breast cancer among women who had mammograms every two years compared to women screened every six years raising the possibility that some breast cancers just regress naturally without treatment.
Ipsogen Launches A New Test To Determine Tumor HER2 Status And Guide Herceptin(R) Prescription In Breast Cancer
http://www.medicalnewstoday.com/articles/130627.php
IPSOGEN SA (Marseille, France and New Haven, CT, USA), a cancer profiler that markets molecular diagnostic assays for leukemia and breast cancer announced the European launch of MapQuant Dx(TM) HER2 test.
Mammograms May Detect Some Cancers That Would Have Otherwise Regressed
http://www.medicalnewstoday.com/articles/130603.php
Breast cancer rates increased significantly in four Norwegian counties after women there began undergoing mammography every two years, according to a report in the November 24 issue of <i>Archives of Internal Medicine,</i> one of the <i>JAMA/Archives</i> journals.
----------------------------------------------
** CANCER / ONCOLOGY News **
Exelixis And Bristol-Myers Squibb To Co-Develop XL413, A Selective Cdc7 Inhibitor
http://www.medicalnewstoday.com/articles/130798.php
Exelixis, Inc. (Nasdaq:EXEL) today announced that Bristol-Myers Squibb Company (NYSE:BMY) has exercised its option to develop and commercialize Exelixis' investigational new drug (IND) candidate XL413, a selective inhibitor of Cdc7.
Varian Medical Systems Introducing OncoView™ - An Oncology Specific Image Management And Storage Solution
http://www.medicalnewstoday.com/articles/130790.php
Varian Medical Systems (NYSE: VAR) today is introducing a new product that makes it easier for clinicians to store, manage and view images generated during cancer treatments. Varian will showcase its new OncoView™ image management and storage solution at the Radiological Society of North America (RSNA) meeting in Chicago, November 30 - December 4, 2008.
National Comprehensive Cancer Network Receives $1.5 Million Grant To Research Targeted Therapy In Bladder Cancer
http://www.medicalnewstoday.com/articles/130780.php
NCCN (The National Comprehensive Cancer Network) has been awarded a $1.5 Million grant from Bristol-Myers Squibb Company and ImClone Systems Incorporated to fund research on the antibody cetuximab in patients with bladder cancer.
BloodCenter Of Wisconsin Launches New Test To Diagnose Resistance To Common Cancer Therapy
http://www.medicalnewstoday.com/articles/130773.php
BloodCenter of Wisconsin today announced the availability of BCR-ABL Kinase Domain Mutation Analysis, a new DNA sequencing assay designed to help oncologists develop appropriate therapeutic strategies tailored to the specific needs of patients with chronic myeloid (or myelogenous) leukemia (CML).
Clot Risk Increased By Transfusions In Hospitalized Cancer Patients
http://www.medicalnewstoday.com/articles/130755.php
Blood transfusions used to treat anemia in patients with cancer are associated with an increased risk of life-threatening blood clots, at a similar rate as other treatments for cancer-induced anemia, according to scientists at the University of Rochester Medical Center.
Novel Device May Enhance Chemotherapy Treatment In Brain Tumors
http://www.medicalnewstoday.com/articles/130743.php
NovoCure Ltd. presented results evaluating the Novo-TTF device in vitro and in a pilot clinical trial that showed the device enhanced the efficacy of standard chemotherapy (temozolomide) treatment in newly-diagnosed glioblastoma multiforme (GBM) patients.
Commercialisation Of Yondelis(R) For The Treatment Of Soft Tissue Sarcoma Approved In Russia
http://www.medicalnewstoday.com/articles/130720.php
The Russian regulatory body has approved YONDELIS® (trabectedin) for the treatment of soft tissue sarcoma in adults. This represents another approval for YONDELIS® for treatment soft tissue sarcoma (STS) following upon its approval in Europe in September 2007, which opens up new opportunities in markets with enormous growth potential.
Breakthrough Breast Cancer Comment Re Research Suggesting Breast Screening May Detect Cancers That Would Have Otherwise Regressed
http://www.medicalnewstoday.com/articles/130669.php
Dr Alexis Willett from Breakthrough Breast Cancer says: "This research puts forward an interesting theory about breast cancer development. However, it is not currently possible to predict whether early changes picked up by breast screening will progress so treatment is usually offered to prevent breast cancer developing.
Mammograms May Identify Cancers That Would Otherwise Just Regress
http://www.medicalnewstoday.com/articles/130644.php
Researchers in Norway found there was a 22 per cent higher rate of detected breast cancer among women who had mammograms every two years compared to women screened every six years raising the possibility that some breast cancers just regress naturally without treatment.
December Is Cancer-Related Fatigue Awareness Month
http://www.medicalnewstoday.com/articles/130638.php
Between 70 and 100 percent of cancer patients receiving treatment have fatigue, according to the American Cancer Society. Up to one-half of all survivors have reported fatigue lasting months or even years after treatment.
New Cancer Treatment Shrinks Pancreatic Tumor
http://www.medicalnewstoday.com/articles/130628.php
A new cancer treatment is realizing outstanding results against pancreatic cancer. Following five weeks of treatment, a patient's large, stage 4 tumor was reduced in size by 70%. After seven more weeks of treatment, it no longer could be definitely identified on scans.
Medarex Announces Initiation Of Phase 1b Clinical Development Program With MDX-1106 For The Treatment Of Cancer
http://www.medicalnewstoday.com/articles/130625.php
Medarex, Inc. (Nasdaq: MEDX) announced it has initiated a Phase 1b clinical trial for MDX-1106 (ONO-4538: development code of Ono Pharmaceutical Co., Ltd.), a fully human anti-PD-1 antibody for the treatment of cancer.
ASGE And The Pancreatic Cancer Action Network Partner To Raise Awareness About Pancreatic Cancer
http://www.medicalnewstoday.com/articles/130621.php
The American Society for Gastrointestinal Endoscopy (ASGE) and the Pancreatic Cancer Action Network are teaming up this November to raise awareness about pancreatic cancer, educating patients about the disease and the resources that are available for them.
UM Study Finds Late Diagnosis And Under-Treatment To Blame For Disparities In Cervical Cancer Survival
http://www.medicalnewstoday.com/articles/130618.php
Disparities in cervical cancer survival can be traced to differences in access to care for certain racial, ethnic and socioeconomic groups, according to a University of Miami Miller School of Medicine study of more than 5,300 Florida women.
The Improvement Foundation's Groundbreaking Cancer Programme - Improving Public Awareness And Fast Referral Of Cancer, UK
http://www.medicalnewstoday.com/articles/130617.php
Under a 'National Awareness and Early Diagnosis Initiative' (NAEDI), launched by the Department of Health last week, work is already underway in the UK to improve public awareness and fast referral of cancer, with pilot schemes in 20 Primary Care Trusts (PCTs) run by the Improvement Foundation.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
UM Study Finds Late Diagnosis And Under-Treatment To Blame For Disparities In Cervical Cancer Survival
http://www.medicalnewstoday.com/articles/130618.php
Disparities in cervical cancer survival can be traced to differences in access to care for certain racial, ethnic and socioeconomic groups, according to a University of Miami Miller School of Medicine study of more than 5,300 Florida women.
----------------------------------------------
** COLORECTAL CANCER News **
Genomic Signature Of Colon Cancer May Individualize Treatment
http://www.medicalnewstoday.com/articles/130730.php
Researchers in the Duke Institute for Genome Sciences & Policy have developed a model for predicting risk of recurrence in early stage colon cancer patients, and have used the model to also predict sensitivity to chemotherapy and targeted therapy regimens.
----------------------------------------------
** LUNG CANCER News **
European Cancer Specialists Mandate For Change - Better Emotional Support And Resouces For Lung Cancer Patients
http://www.medicalnewstoday.com/articles/130652.php
A coalition of European cancer specialists today called for major changes in the provision of emotional support for lung cancer patients. In conjunction with the International Psycho-Oncology Society, they issued a <i>Mandate for Change,</i> highlighting basic rights for patients in terms of their emotional wellbeing and quality of life.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
U.S. Approval For Clolar(R) To Treat Adult Acute Myeloid Leukemia Sought By Genzyme
http://www.medicalnewstoday.com/articles/130777.php
Genzyme Corporation (Nasdaq: GENZ) announced today that it has filed a supplemental New Drug Application with the U.S. Food and Drug Administration for the use of Clolar® (clofarabine) to treat adult patients with acute myeloid leukemia (AML).
FDA Grants Pralatrexate Orphan Drug Designation For The Treatment Of Patients With Diffuse Large B-Cell Lymphoma
http://www.medicalnewstoday.com/articles/130765.php
Allos Therapeutics, Inc. (Nasdaq: ALTH), a biopharmaceutical company focused on the development and commercialization of small molecule therapeutics for the treatment of cancer, today announced that the U.
Potential New Drug Target For Chronic Leukemia Identified By UCSD Researchers
http://www.medicalnewstoday.com/articles/130721.php
Researchers at the University of California, San Diego (UCSD) and the Moores UCSD Cancer Center have discovered what could be a novel drug target for an often difficult-to-treat form of leukemia.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
USC Researchers Identify Novel Approach For Suppressing Prostate Cancer Development
http://www.medicalnewstoday.com/articles/130656.php
Inactivation of a specific protein associated with cancer development halts prostate tumor progression in animal model Los Angeles, Calif. Nov. 24, 2008 California (USC) have found that inactivating a specific biomarker for aggressive prostate cancer blocks the development of prostate cancer in animal models.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment